National Health Net Worth
National Health Net Worth Breakdown | NHI |
National Health Net Worth Analysis
National Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including National Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of National Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform National Health's net worth analysis. One common approach is to calculate National Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares National Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing National Health's net worth. This approach calculates the present value of National Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of National Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate National Health's net worth. This involves comparing National Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into National Health's net worth relative to its peers.
Enterprise Value |
|
To determine if National Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding National Health's net worth research are outlined below:
| National Health has a strong financial position based on the latest SEC filings | |
| About 70.0% of the company shares are owned by institutional investors | |
| On 29th of January 2025 National Health paid $ 0.9 per share dividend to its current shareholders | |
| Latest headline from kalkinemedia.com: Is National Health Investors Seeing Increased Institutional Confidence |
National Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in National Health Investors. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to National Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
National Health Target Price Consensus
National target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. National Health's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 8 | Buy |
Most National analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand National stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of National Health Investors, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationNational Health Target Price Projection
National Health's current and average target prices are 73.34 and 79.57, respectively. The current price of National Health is the price at which National Health Investors is currently trading. On the other hand, National Health's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
National Health Market Quote on 24th of March 2025
Target Price
Analyst Consensus On National Health Target Price
Know National Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as National Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading National Health Investors backward and forwards among themselves. National Health's institutional investor refers to the entity that pools money to purchase National Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Norges Bank | 2024-12-31 | 610.7 K | Bank Of New York Mellon Corp | 2024-12-31 | 557.4 K | Marshall Wace Asset Management Ltd | 2024-12-31 | 551.6 K | Millennium Management Llc | 488.4 K | Prudential Financial Inc | 2024-12-31 | 476.4 K | Land & Buildings Investment Mgmt, Llc | 2024-12-31 | 467.1 K | Sumitomo Mitsui Trust Group Inc | 2024-12-31 | 463.4 K | Centersquare Investment Management Llc | 2024-12-31 | 394.4 K | Mirae Asset Global Etfs Holdings Ltd. | 2024-12-31 | 390.1 K | Vanguard Group Inc | 2024-12-31 | 6.4 M | Blackrock Inc | 2024-12-31 | 4.6 M |
Follow National Health's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 3.35 B.Market Cap |
|
Project National Health's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.05 | 0.08 | |
| Return On Capital Employed | 0.08 | 0.09 | |
| Return On Assets | 0.05 | 0.08 | |
| Return On Equity | 0.10 | 0.10 |
When accessing National Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures National Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of National Health's profitability and make more informed investment decisions.
Evaluate National Health's management efficiency
National Health Investors has Return on Asset of 0.0463 % which means that on every $100 spent on assets, it made $0.0463 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1028 %, implying that it generated $0.1028 on every 100 dollars invested. National Health's management efficiency ratios could be used to measure how well National Health manages its routine affairs as well as how well it operates its assets and liabilities. As of now, National Health's Return On Tangible Assets are decreasing as compared to previous years. The National Health's current Return On Capital Employed is estimated to increase to 0.09, while Return On Equity is projected to decrease to 0.1. As of now, National Health's Return On Tangible Assets are decreasing as compared to previous years. The National Health's current Debt To Assets is estimated to increase to 0.44, while Total Assets are projected to decrease to under 1.4 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 31.59 | 16.75 | |
| Tangible Book Value Per Share | 31.59 | 25.58 | |
| Enterprise Value Over EBITDA | 15.75 | 11.82 | |
| Price Book Value Ratio | 2.22 | 2.11 | |
| Enterprise Value Multiple | 15.75 | 11.82 | |
| Price Fair Value | 2.22 | 2.11 | |
| Enterprise Value | 4.2 B | 4.4 B |
Examining the leadership quality of National Health Investors offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Enterprise Value Revenue 13.3436 | Revenue | Quarterly Revenue Growth (0.12) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific National Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on National Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases National Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
National Health Corporate Filings
F4 | 5th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 25th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
| 19th of February 2025 Other Reports | ViewVerify | |
8K | 10th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
National Health Earnings Estimation Breakdown
The calculation of National Health's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of National Health is estimated to be 0.0 with the future projection ranging from a low of 0.0 to a high of 0.0. Please be aware that this consensus of annual earnings estimates for National Health Investors is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.00 Lowest | Expected EPS | 0.00 Highest |
National Health Earnings Projection Consensus
Suppose the current estimates of National Health's value are higher than the current market price of the National Health stock. In this case, investors may conclude that National Health is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and National Health's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 8 | 83.39% | 0.8133 | 0.0 | 3.13 |
National Health Earnings per Share Projection vs Actual
Actual Earning per Share of National Health refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering National Health Investors predict the company's earnings will be in the future. The higher the earnings per share of National Health, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.National Health Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as National Health, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of National Health should always be considered in relation to other companies to make a more educated investment decision.National Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact National Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-18 | 2024-12-31 | 0.7514 | 0.8133 | 0.0619 | 8 | ||
2024-11-05 | 2024-09-30 | 0.73 | 0.65 | -0.08 | 10 | ||
2024-08-06 | 2024-06-30 | 0.74 | 0.81 | 0.07 | 9 | ||
2024-05-06 | 2024-03-31 | 0.68 | 0.71 | 0.03 | 4 | ||
2024-02-20 | 2023-12-31 | 0.68 | 0.74 | 0.06 | 8 | ||
2023-11-07 | 2023-09-30 | 0.72 | 0.68 | -0.04 | 5 | ||
2023-08-08 | 2023-06-30 | 0.69 | 0.92 | 0.23 | 33 | ||
2023-05-09 | 2023-03-31 | 0.85 | 0.79 | -0.06 | 7 | ||
2023-02-21 | 2022-12-31 | 0.83 | 0.04 | -0.79 | 95 | ||
2022-11-08 | 2022-09-30 | 0.77 | 0.78 | 0.01 | 1 | ||
2022-08-08 | 2022-06-30 | 0.73 | 0.48 | -0.25 | 34 | ||
2022-05-09 | 2022-03-31 | 0.63 | 0.18 | -0.45 | 71 | ||
2022-02-22 | 2021-12-31 | 0.93 | 0.14 | -0.79 | 84 | ||
2021-11-08 | 2021-09-30 | 1.21 | 0.67 | -0.54 | 44 | ||
2021-08-09 | 2021-06-30 | 0.9 | 0.85 | -0.05 | 5 | ||
2021-05-10 | 2021-03-31 | 0.89 | 0.78 | -0.11 | 12 | ||
2021-02-22 | 2020-12-31 | 1.01 | 0.82 | -0.19 | 18 | ||
2020-11-09 | 2020-09-30 | 0.93 | 0.95 | 0.02 | 2 | ||
2020-08-10 | 2020-06-30 | 1 | 0.99 | -0.01 | 1 | ||
2020-05-11 | 2020-03-31 | 0.95 | 1.37 | 0.42 | 44 | ||
2020-02-19 | 2019-12-31 | 0.95 | 0.95 | 0.0 | 0 | ||
2019-11-07 | 2019-09-30 | 0.95 | 0.97 | 0.02 | 2 | ||
2019-08-08 | 2019-06-30 | 0.96 | 0.92 | -0.04 | 4 | ||
2019-05-07 | 2019-03-31 | 0.94 | 0.91 | -0.03 | 3 | ||
2019-02-19 | 2018-12-31 | 0.96 | 0.87 | -0.09 | 9 | ||
2018-11-06 | 2018-09-30 | 0.96 | 0.97 | 0.01 | 1 | ||
2018-08-07 | 2018-06-30 | 0.96 | 0.95 | -0.01 | 1 | ||
2018-05-08 | 2018-03-31 | 0.92 | 0.92 | 0.0 | 0 | ||
2018-02-16 | 2017-12-31 | 0.92 | 0.9 | -0.02 | 2 | ||
2017-11-08 | 2017-09-30 | 0.91 | 0.94 | 0.03 | 3 | ||
2017-08-09 | 2017-06-30 | 0.87 | 0.93 | 0.06 | 6 | ||
2017-05-09 | 2017-03-31 | 0.84 | 1.1 | 0.26 | 30 | ||
2017-02-17 | 2016-12-31 | 0.87 | 1.03 | 0.16 | 18 | ||
2016-11-07 | 2016-09-30 | 0.87 | 0.83 | -0.04 | 4 | ||
2016-08-05 | 2016-06-30 | 0.74 | 1.16 | 0.42 | 56 | ||
2016-05-06 | 2016-03-31 | 0.84 | 0.85 | 0.01 | 1 | ||
2016-02-18 | 2015-12-31 | 0.83 | 1.44 | 0.61 | 73 | ||
2015-11-05 | 2015-09-30 | 0.83 | 0.89 | 0.06 | 7 | ||
2015-08-05 | 2015-06-30 | 0.83 | 0.82 | -0.01 | 1 | ||
2015-05-07 | 2015-03-31 | 0.84 | 0.79 | -0.05 | 5 | ||
2015-02-17 | 2014-12-31 | 0.81 | 0.8 | -0.01 | 1 | ||
2014-11-03 | 2014-09-30 | 0.79 | 0.76 | -0.03 | 3 | ||
2014-08-04 | 2014-06-30 | 0.79 | 0.76 | -0.03 | 3 | ||
2014-05-05 | 2014-03-31 | 0.79 | 0.71 | -0.08 | 10 | ||
2014-02-18 | 2013-12-31 | 0.7 | 0.83 | 0.13 | 18 | ||
2013-11-04 | 2013-09-30 | 0.74 | 0.84 | 0.1 | 13 | ||
2013-08-06 | 2013-06-30 | 0.73 | 0.71 | -0.02 | 2 | ||
2013-05-06 | 2013-03-31 | 0.66 | 0.7 | 0.04 | 6 | ||
2013-02-14 | 2012-12-31 | 0.66 | 1.48 | 0.82 | 124 | ||
2012-11-05 | 2012-09-30 | 0.7 | 0.52 | -0.18 | 25 | ||
2012-08-06 | 2012-06-30 | 0.67 | 0.61 | -0.06 | 8 | ||
2012-05-10 | 2012-03-31 | 0.6 | 0.62 | 0.02 | 3 | ||
2012-02-15 | 2011-12-31 | 0.66 | 0.65 | -0.01 | 1 | ||
2011-11-07 | 2011-09-30 | 0.63 | 0.68 | 0.05 | 7 | ||
2011-08-04 | 2011-06-30 | 0.61 | 0.9 | 0.29 | 47 | ||
2011-05-05 | 2011-03-31 | 0.61 | 0.69 | 0.08 | 13 | ||
2011-02-17 | 2010-12-31 | 0.61 | 0.61 | 0.0 | 0 | ||
2010-11-04 | 2010-09-30 | 0.59 | 0.62 | 0.03 | 5 | ||
2010-08-03 | 2010-06-30 | 0.57 | 0.67 | 0.1 | 17 | ||
2010-05-10 | 2010-03-31 | 0.53 | 0.58 | 0.05 | 9 | ||
2010-02-22 | 2009-12-31 | 0.55 | 0.58 | 0.03 | 5 | ||
2009-10-30 | 2009-09-30 | 0.57 | 0.63 | 0.06 | 10 | ||
2004-08-05 | 2004-06-30 | 0.43 | 0.4 | -0.03 | 6 | ||
2003-10-21 | 2003-09-30 | 0.35 | 0.43 | 0.08 | 22 | ||
2003-07-22 | 2003-06-30 | 0.32 | 0.39 | 0.07 | 21 |
National Health Corporate Directors
| Robert Adams | Independent Director | Profile | |
| James Jobe | Independent Director | Profile | |
| Robert Webb | Independent Director | Profile | |
| Dana Hambly | Director of Investor Relations | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 3.13 | Revenue Per Share | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.